Friday, February 26, 2021
Home Life Style Health & Fitness WHO Plans To Enhance It’s Combat Against Snakebites

WHO Plans To Enhance It’s Combat Against Snakebites

WHO estimates venomous snakes bite 1.8 million to 2.7 million people a year

Governments around the world plan to strike back harder against snakebite, a scourge that kills tens of thousands of people a year.

A World Health Organization (WHO) resolution raises the priority of improving snakebite prevention as well as access to effective and affordable anti-venom. The measure was approved by 192 countries in late May.

The WHO estimates that venomous snakes bite 1.8 million to 2.7 million people a year, killing between 81,000 and 138,000 of them.

“For every person who dies following a snakebite, another four or five are left with disabilities such as blindness, restricted mobility or amputation, and post-traumatic stress disorder,” the WHO reports.

Snakebite envenoming is most prevalent in sub-Saharan Africa, South Asia and Southeast Asia, the WHO reports. People in rural, impoverished areas there and elsewhere are most at risk, challenged by poor or remote health systems, and limited diagnoses, ambulances and other emergency care – including reliable anti-venom.

Grass snake
Grass snake, Flickr

In sub-Saharan Africa, just 2 percent of people bitten by venomous snakes have access to appropriate anti-venom, says Medecins Sans Frontieres (MSF), the aid group also known as Doctors Without Borders.

“We need to know better the data [on] where most cases take place,” said Julien Potet, MSF’s policy adviser on neglected tropical diseases, speaking by phone last week from Geneva. “We need to better regulate the quality of the anti-venoms, to distribute them accordingly in the areas of highest need” and to make them affordable, “because otherwise they [patients] will not be able to access the product.”

Potet pointed out that French pharmaceutical company Sanofi Pasteur has stopped manufacturing Fav-Afrique, the only serum known to effectively treat bites from some sub-Saharan African snakes. The last batches of the company’s serum expired in June 2016.

Production of the anti-venom takes roughly two years, the in-Pharma Technologist website reported. It said the pharmaceutical company cited manufacturing costs, and competition from cheaper but less effective treatments, in its decision to stop producing Fav-Afrique.

MSF has estimated that the anti-venom costs a patient $250 to $500 for treatment.

Sanofi Pasteur announced in January that it had agreed to divest its anti-venom immunoglobulin range, which includes Fav-Afrique, to the U.K.-based firm MicroPharm.

“We hope this resolution will trigger some actions to better regulate the market … and to prioritize and subsidize” anti-venom production and distribution, Potet said.

“Now we need to make sure this resolution is translated into a concrete, fully funded action plan,” he added.

A researcher demonstrates how to extract venom from a snake to vacationing school children during a presentation at the Butantan Institute in Sao Paulo, Brazil, Jan. 23, 2015
A researcher demonstrates how to extract venom from a snake to vacationing school children during a presentation at the Butantan Institute in Sao Paulo, Brazil, Jan. 23, 2015, VOA

A WHO working group is expected to offer recommendations on how governments can bolster data collection, training for health workers, access to care and support for effective anti-venoms, according to Devex, a website aimed at the global development community. It said the group’s report is expected by Nov. 30.

Also read: Australian snakes have Asian origins study

Devex also reported that David Williams, the group’s chair, estimated “about $6 million was needed in 2018-2019 to prepare the recommendations, improve surveillance, deliver antivenoms, and address other technical and medical challenges.” (VOA)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Indian Firms Are Still Far From Digital Empathy

As more and more Indians adopt a digital way of life most organizations are still a long way from authentically displaying "digital empathy" and...

Children’s Book To Keep Young Readers Company

With an unprecedented year of transformation in education, children's reading has gained a new significance. Here are new children's titles from Talking Cub and...

Study: Mental Well-Being Impacted By Pandemic’s Social Consequences

As the country continues to battle the coronavirus, young adults in college say that their mental well-being has been most impacted by the pandemic's...

World NGO Day 2021: Why is it celebrated? (Significance and Facts)

The term NGO stands for a Non-Governmental organization, and it includes a variety of organizations such as “private voluntary organizations,” “civil society organizations,” and...

68 Percent Women Feel Insecured Due To Rejections Based On Beauty

According to a recent survey, nine out of ten women in India feel they are judged and rejected based on their looks during the...

Five Things To Be Mindful Of Before Buying A House In 2021

Owning a home is something all of us have dreamt of at some point in time in our lives. At the very outset, the...

An Agreement To Boost Online Jewellery Retail

To provide impetus to Indian gem and jewelry sellers on the global e-marketplace and explore potential business collaborations for sectoral growth, the Gem and...

Work on India’s First-Ever Cable-Styled Bridge Called “Anji” Goes on in Full Swing!

Work on India's first cable-styled bridge, also called the Anji bridge, is going on in full swing in Jammu and Kashmir's Raesi district, and...

Recent Comments